Gala Pharmaceutical Inc. Debt Instrument, Convertible, Beneficial Conversion Feature
Gala Pharmaceutical Inc. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $175.43 thousand for the 12-month period ending 2017-11-30, per its 10-K filed 2018-04-06.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2018-04-06
- Gala Pharmaceutical Inc. debt instrument, convertible, beneficial conversion feature for fiscal 2017 was $175.43K.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|
| 2017-11-30 | $175.43K 10-K · filed 2018-04-06 |